TMCnet News

Research and Markets: Global Allergic Asthma Pipeline Review 2015

[May 27, 2015]

Research and Markets: Global Allergic Asthma Pipeline Review 2015

Research and Markets (http://www.researchandmarkets.com/research/d9rr3l/allergic_asthma) has announced the addition of the "Allergic Asthma - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Allergic Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Asthma and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

ALK-Abello A/S
Allergopharma Joachim Ganzer KG
Array BioPharma Inc.
Aslan Pharmaceuticals Pte. Ltd.
Asmacure Ltee
BioTech Tools s.a.
Fountain Biopharma Inc.
Genentech, Inc.
Infinity Pharmaceuticals, Inc.
Kineta, Inc.
Marinomed Biotechnologie GmbH
NeoPharm Co., Ltd.
Novartis AG
Nuvo Research Inc.
Panacea Biotec Limited
Peptinnovate Limited
Pharmaxis Limited
Portola Pharmaceuticals, Inc.
Protectimmun GmbH
Pulmatrix, Inc.
Stallergenes S.A.
sterna biologicals Gmbh & Co KG
Verona Pharma Plc

For more information visit http://www.researchandmarkets.com/research/d9rr3l/allergic_asthma

View source version on businesswire.com: http://www.businesswire.com/news/home/20150527006730/en/

[ Back To TMCnet.com's Homepage ]